» Articles » PMID: 6231307

Relationship Between Systemic Lupus Erythematosus T Cell Subsets, Anti-T Cell Antibodies, and T Cell Functions

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1984 Mar 1
PMID 6231307
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have shown that patients with systemic lupus erythematosus (SLE) had differing T cell T4+/T8+ ratios and that the ratio correlated with clinical features of the disease. In the present study, we wished to determine whether the peripheral blood T cell subsets in these patients were related to the specificity of anti-T cell antibodies found in their plasma. Plasma from 24 SLE patients that reacted with greater than 20% of normal T cells were analyzed for their effect on in vitro pokeweed mitogen-stimulated immunoglobulin synthesis and for their reactivity with human T4+ and T8+ cells. Anti-T cell antibodies found in SLE patients have a spectrum of reactivities. We concentrated upon antibodies that interfere with suppressor function. One group of SLE anti-T cell antibodies reacts preferentially with the T8+ suppressor effector cell whereas another is reactive with T4+ suppressor inducer subsets. SLE patients with high T4+/T8+ ratios had anti-T cell antibodies predominantly reactive with the T8+ suppressor effector cells. Patients with low T4+/T8+ ratios, on the other hand, had anti-T cell antibodies reactive with either the T4+ suppressor inducer or with both the T4+ suppressor inducer and T8+ suppressor effector cells. In addition, a fourth group was defined whose anti-T cell antibodies were neither reactive with a functional T4+ suppressor inducer nor a functional T8+ suppressor effector cells. There was a significant correlation between the circulating T4+/T8+ ratio of peripheral T cells in these patients and the relative ability of their anti-T cell antibodies to kill T8+ cells vs. T4+ cells (gamma = 0.666, P less than 0.001). These results support the notion that in SLE different cellular defects in the immunoregulatory circuit underlie the development of autoimmune reactions and that the anti-T cell antibodies may cause numerical and functional deficiencies in T cell subsets.

Citing Articles

Idiopathic CD4+ lymphocytopenia in Hispanic male: case report and literature review.

Said S, Alkhateeb H, Cooper C, Rodriguez E, Trien R, Hernandez G Int Med Case Rep J. 2014; 7:117-20.

PMID: 25114596 PMC: 4124073. DOI: 10.2147/IMCRJ.S63836.


Idiopathic CD4 Lymphocytopenia: Spectrum of opportunistic infections, malignancies, and autoimmune diseases.

Ahmad D, Esmadi M, Steinmann W Avicenna J Med. 2013; 3(2):37-47.

PMID: 23930241 PMC: 3734630. DOI: 10.4103/2231-0770.114121.


Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders.

Goyal R, Bulua A, Nikolov N, Schwartzberg P, Siegel R Curr Opin Rheumatol. 2008; 21(1):78-84.

PMID: 19077721 PMC: 2760066. DOI: 10.1097/BOR.0b013e32831cb939.


Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases.

Al-Dalaan A, Raziuddin S J Clin Immunol. 1993; 13(1):58-67.

PMID: 8445045 DOI: 10.1007/BF00920636.


Lymphocytotoxic antibodies in SLE: a review of the literature.

Osman C, Swaak A Clin Rheumatol. 1994; 13(1):21-7.

PMID: 8187440 DOI: 10.1007/BF02229861.


References
1.
Koffler D, Schur P, KUNKEL H . Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med. 1967; 126(4):607-24. PMC: 2138388. DOI: 10.1084/jem.126.4.607. View

2.
Stastny P, ZIFF M . Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes. Clin Exp Immunol. 1971; 8(4):543-50. PMC: 1712965. View

3.
Horwitz D . Impaired delayed hypersensitivity in systemic lupus erythematosus. Arthritis Rheum. 1972; 15(4):353-9. DOI: 10.1002/art.1780150406. View

4.
Lies R, Messner R, Williams Jr R . Relative T-cell specificity of lymphocytotoxins from patients with systemic lupus erythematosus. Arthritis Rheum. 1973; 16(3):369-75. DOI: 10.1002/art.1780160312. View

5.
Hahn B, Bagby K, Osterland C . Abnormalities of delayed hypersensitivity in systemic lupus erythematosus. Am J Med. 1973; 55(1):25-31. DOI: 10.1016/0002-9343(73)90146-0. View